Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0121 Local Bladder 11/15/2002 6/1/2005 9%
    Closed S0120 Observational MGUS / Asymptomatic Myeloma and Plasma Proliferative Disorders 6/1/2002 4/1/2011 97% Published
    Closed S0119 Gemcitabine/Irinotecan Untreated Extensive SCLC 1/1/2002 2/15/2003 100% Published
    Closed S0117 Phase II Mylotarg™ for Relapsed AML 4/1/2003 10/15/2005 60%
    Closed S0116 D1/3-MAGE-3 His Protein + SB-AS02B/Selected Stage IV, M1a or M1b 9/15/2002 2/15/2004 2%
    Closed S0115 Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study 1/1/2004 10/15/2010 95% Published
    Closed S0114 EGFRvIII Peptide Vaccine 11/1/2002 6/1/2006 47%
    Closed S0112 Elderly AML 8/1/2001 4/1/2003 100% Published
    Closed S0111 Advanced Prostate 6/15/2001 11/15/2003 100% Published
    Closed S0109 Advanced Renal 5/1/2001 2/1/2002 100% Published
    Closed S0108 NON-HODGKIN'S: Bevacizumab For Relapsed Aggressive NHL 4/15/2001 12/1/2004 87% Published
    Closed S0107 PANCREAS 7/1/2001 6/1/2003 100% Published
    Closed S0106 Phase III Starndard + Mylotarg vs. Standard + Daunomycin/Ara-C for AML Under Age 61 5/15/2004 8/20/2009 93% Published
    Closed S0102 ADVANCED: Doxetaxel/Vinorelbine/Filgrastim for HER-2 Neg Stage IV Breast Cancer 5/1/2001 1/1/2004 100% Published
    Closed S0101 ESOPHAGEAL 4/15/2001 2/1/2003 100% Published
    Closed S0033 Gastrointestinal Stromal Tumor 12/15/2000 9/1/2001 100% Published
    Closed S0032 Advanced Prostate 12/1/2001 6/1/2005 48% Published
    Closed S0031 Advanced Bladder 2/15/2001 10/15/2002 56% Published
    Closed S0030 COLORECTAL 2/1/2003 2/1/2005 48% Published
    Closed S0029 ADVANCED: Docetaxel for Metastatic Breast Cancer 8/1/2001 6/15/2005 34%
    Scroll Table